Dublin, Feb. 06, 2017 -- Research and Markets has announced the addition of the "Global Organ Preservation Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
The Global Organ Preservation Market is poised to grow at a CAGR of around 8.6% over the next decade to reach approximately $335.8 million by 2025. Some of the prominent trends that the market is witnessing include increasing compensation treatment for organ transplantation procedures, technical advancements and increasing elderly population, rising multi-organ breakdown cases in aging inhabitants, growth opportunities/investment opportunities.
Based on technique the market is categorized into hypothermic machine perfusion, static cold storage (SCS) technique, normothermic machine perfusion and other techniques. As per organ type the market is segmented into liver, lung, kidneys, heart, and other organs. Other organs are further segmented into pancreas and intestine.
By solution, the market is categorized into custodiol htk - (histidine-tryptophan-ketoglutarate) solution, human biosystem (hbs) solution, hypothermosol, lifor, perfadex, renograf, sirna transplant solution, university of wisconsin solution (uw solution), viaspan and other preservation solutions.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
Report Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities;
- Market forecasts till 2025, using estimated market values as the base numbers;
- Key market trends across the business segments, Regions and Countries;
- Key developments and strategies observed in the market;
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends;
- In-depth company profiles of key players and upcoming prominent players;
- Growth prospects among the emerging nations through 2025;
- Market opportunities and recommendations for new investments.
Companies Mentioned:
- 21st Century Medicine Inc.
- Bridge to Life Limited
- Bristol-Myers Squibb
- Claris Lifesciences Limited
- Dr. Franz Kohler Chemie GmbH
- Essential Pharmaceuticals, LLC
- Lifeline Scientific, Inc. (Organ Recovery Systems, Inc.)
- Organox Limited
- Paragonix Technologies, Inc.
- Preservation Solutions, Inc.
- Teva Pharmaceutical Industries Ltd.
- ToleroTech, Inc.
- Transmedics, Inc.
- Waters Medical Systems LLC [Institut Georges Lopez (IGL]
- Xvivo Perfusion AB
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
4 Organ Preservation Market, By Technique
5 Organ Preservation Market, By Organ Type
6 Organ Preservation Market, By Solution
7 Organ Preservation Market, By Geography
8 Key Player Activities
9 Leading Companies
For more information about this report visit http://www.researchandmarkets.com/research/63glxw/global_organ
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Blood Banking


DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



